OMB APPROVAL |
||
OMB Number: 3235-0101
Expires: December 31, 2009 Estimated average burden hours per response......... 2.00 |
||
SEC USE ONLY |
||
DOCUMENT SEQUENCE NO. |
||
CUSIP NUMBER |
||
WORK
LOCATION |
||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
ATTENTION: | Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker. |
1 (a) NAME OF ISSUER (Please type or print) | (b) IRS IDENT. NO. | (c) S.E.C. FILE NO. | ||||||||||||||||||||
Natural Health Trends Corp. | 59-2705336 | 0-26272 | ||||||||||||||||||||
1 (d)
ADDRESS OF ISSUER
|
STREET | CITY | STATE | ZIP CODE | (e) TELEPHONE NO. | |||||||||||||||||
AREA CODE | NUMBER | |||||||||||||||||||||
2050 Diplomat Drive | Dallas | Texas | 75234 | 972 | 241-4080 | |||||||||||||||||
2 (a)
NAME OF PERSON FOR WHOSE ACCOUNT THE
SECURITIES ARE TO BE SOLD
|
(b) IRS IDENT. NO. | (c) RELATIONSHIP TO ISSUER |
(d) ADDRESS STREET | CITY | STATE | ZIP CODE | ||||||||||||||||
Gary C. Wallace
|
N/A | Officer | 2050 Diplomat Drive | Dallas | Texas | 75234 | ||||||||||||||||
3 (a) | (b) | SEC USE ONLY | (c) | (d) | (e) | (f) | (g) | ||||||||||||||||||||||
Title of the | Name and Address of Each Broker Through Whom the | Broker-Dealer | Number of Shares | Aggregate | Number of Shares | Approximate | Name of Each | ||||||||||||||||||||||
Class of | Securities are to be Offered or Each Market Maker | File Number | or Other Units | Market | or Other Units | Date of Sale | Securities | ||||||||||||||||||||||
Securities | who is Acquiring the Securities | To Be Sold | Value | Outstanding | (See instr. 3(f)) | Exchange | |||||||||||||||||||||||
To Be Sold | (See instr. 3(c)) | (See instr. 3(d)) | (See instr. 3(e)) | (MO. DAY YR.) | (See instr. 3(g)) | ||||||||||||||||||||||||
Common Stock
|
E*Trade | 583 | $ | 204.13 | ******* | 12/16/08 | Nasdaq Capital | ||||||||||||||||||||||
671 N. Glebe Road, 11th Floor | (per12/15/08 | Market | |||||||||||||||||||||||||||
Arlington, Virginia 22203 | closing price) | ||||||||||||||||||||||||||||
Common Stock
|
E*Trade | 140 | $ | 49.00 | ******** | 12/16/08 | Nasdaq Capital | ||||||||||||||||||||||
671 N. Glebe Road, 11th Floor | (per 12/15/08 | Market | |||||||||||||||||||||||||||
Arlington, Virginia 22203 | closing price) | ||||||||||||||||||||||||||||
Common Stock
|
E*Trade | 467 | $ | 583.45 | ******** | 12/16/08 | Nasdaq Capital | ||||||||||||||||||||||
671 N. Glebe Road, 11th Floor | (per 12/15/08 | Market | |||||||||||||||||||||||||||
Arlington, Virginia 22203 | closing price) | ||||||||||||||||||||||||||||
Common Stock
|
E*Trade | 117 | $ | 40.87 | ******** | 12/16/08 | Nasdaq Capital | ||||||||||||||||||||||
671 N. Glebe Road, 11th Floor | (per 12/15/08 | Market | |||||||||||||||||||||||||||
Arlington, Virginia 22203 | closing price) | ||||||||||||||||||||||||||||
Common Stock
|
E*Trade | 1202 | $ | 877.98 | ******** | 12/16/08 | Nasdaq Capital | ||||||||||||||||||||||
671 N. Glebe Road, 11th Floor | (per 12/15/08 | Market | |||||||||||||||||||||||||||
Arlington, Virginia 22203 | closing price) | ||||||||||||||||||||||||||||
1.
|
(a) | Name of issuer | 3. | (a) | Title of the class of securities to be sold | |||||||
(b) | Issuers I.R.S. Identification Number | (b) | Name and address of each broker through whom the securities are intended to be sold | |||||||||
(c) | Issuers S.E.C. file number, if any | (c) | Number of shares or other units to be sold (if debt securities, give the aggregate face amount) | |||||||||
(d) | Issuers address, including zip code | (d) | Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice | |||||||||
(e) | Issuers telephone number, including area code | (e) | Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer | |||||||||
(f) | Approximate date on which the securities are to be sold | |||||||||||
(g) | Name of each securities exchange, if any, on which the securities are intended to be sold | |||||||||||
2.
|
(a) | Name of person for whose account the securities are to be sold | ||||||||||
(b) | Such persons I.R.S. identification number, if such person is an entity | |||||||||||
(c) | Such persons relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing) | |||||||||||
(d) | Such persons address, including zip code |
Title of | Date you | Name of Person from Whom Acquired | Amount of | Date of | ||||||||||||||||||
the Class | Acquired | Nature of Acquisition Transaction | (If gift, also give date donor acquired) | Securities Acquired | Payment | Nature of Payment | ||||||||||||||||
Common Stock
|
April 21, 2007 | Grant of Restricted Stock | Natural Health Trends Corp. | 25,000 | N/A | N/A | ||||||||||||||||
Common Stock
|
June 26, 2007 | Grant of Restricted Stock | Natural Health Trends Corp. | 6,000 | N/A | N/A | ||||||||||||||||
Common Stock
|
Dec. 31, 2007 | Grant of Restricted Stock | Natural Health Trends Corp. | 5,000 | N/A | N/A | ||||||||||||||||
Common Stock
|
March 15, 2008 | Grant of Restricted Stock | Natural Health Trends Corp. | 20,000 | N/A | N/A | ||||||||||||||||
Common Stock
|
Nov. 13, 2008 | Grant of Restricted Stock | Natural Health Trends Corp. | 51,500 | N/A | N/A | ||||||||||||||||
INSTRUCTIONS:
|
If the securities were purchased and full
payment therefor was not made in cash at the time of
purchase, explain in the table or in a note thereto the
nature of the consideration given. If the
consideration consisted of any note or other
obligation, or if payment was made in installments
describe the arrangement and state when the note or
other obligation was discharged in full or the last
installment paid. |
Amount of | ||||||||||||||||||||||
Name and Address of Seller | Title of Securities Sold | Date of Sale | Securities Acquired | Gross Proceeds | ||||||||||||||||||
REMARKS:
|
The shares covered by this Form 144 are being sold pursuant to Rule 10b5-1(c) sales plans dated June 15, 2007, September 12, 2007, June 6, 2008, and December 15, 2008, respectively, and the representation below regarding the sellers knowledge of material information speaks as of that plan adoption dates for the sales covered by those plans. The proceeds derived from the sale of shares covered by this Form 144 will be applied to the payment of taxes resulting from the vesting of certain of the above referenced shares of restricted stock. The exact number of shares to be sold as indicated in Item 3(c) above is subject to the actual price per share at which shares are sold to generate the proceeds required to pay taxes. |
INSTRUCTIONS:
|
ATTENTION: | ||
See the definition of person in paragraph (a) of
Rule 144. Information is to be given not only as to the
person for whose account the securities are to be sold but
also as to all other persons included in that definition.
In addition, information shall be given as to sales by all
persons whose sales are required by paragraph (e) of Rule
144 to be aggregated with sales for the account of the
person filing this notice.
|
The person for whose account the securities to which this notice relates are
to be sold hereby represents by signing this notice that he does not know
any material adverse information in regard to the current and prospective
operations of the Issuer of the securities to be sold which has not been
publicly disclosed.
|
December 16, 2008 | /s/ Gary C. Wallace | |||
DATE OF NOTICE | (SIGNATURE) |